Product Information

IMATINIB MESYLATE 400 MG TAB is a generic product labeled by Armas Pharmaceuticals Inc., priced at $2.0356 per EA under NDC 72485020330. Its NADAC has been published 251 times since Oct 30, 2019.

FDA first approved this application on Jan 17, 2019. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.

The Low Outlier badge above means this manufacturer's average price in the imatinib mesylate market falls below Q1 − 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

Price Statistics

The NADAC for IMATINIB MESYLATE 400 MG TAB has been published 251 times since Oct 30, 2019, and over the history we have for it it has declined 73.1%. The table below summarizes its recorded NADAC range and movement.

Generic Alternatives

The matcher finds 6 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.